MHLW Warns Of Side Effects For Two More Influenza Drugs
This article was originally published in PharmAsia News
Executive Summary
Besides Tamiflu, whose side effects had been previously cautioned, Japan is calling attention to the occurrence of abnormal behaviors in minors taking influenza treatments GlaxoSmithKline's Relenza (zanamivir) and amantadine. Japan's Ministry of Health, Labor and Welfare has received reports of neuropsychiatric events, including patients jumping out of balconies. On Jan. 29, MHLW revised the drugs' package inserts and called physicians' attentions to these side effects. MHLW asked for parental monitoring for at least two days after a minor takes the flu drugs. (Click here for more-Japanese language